Former New York Congressman Dan Maffei pens an op-ed in The Hill urging leaders in his party to avoid targeting the entire pharmaceutical industry for punishment because of a few bad actors. He explains that most drug manufacturers are focused on research and innovation, which should be promoted, and the industry has been heavily-regulated for decades. Additionally, drug prices are offset by discounts and rebates drug makers negotiate with insurers and pharmacy benefit managers. Read the Congressman’s full op-ed here.
Last Updated on May 7, 2020 by Aimed Alliance
